tiprankstipranks
Enzon Pharmaceuticals (ENZN)
:ENZN
US Market

Enzon Pharmaceuticals (ENZN) Income Statement

Compare
85 Followers

Enzon Pharmaceuticals Income Statement

Last quarter (Q3 2024), Enzon Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Enzon Pharmaceuticals's net income was $254.00K. See Enzon Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 26.00K$ 0.00$ 26.00K$ 701.00K$ 52.00K
Gross Profit
$ 26.00K$ 0.00$ 26.00K$ 701.00K$ 52.00K
Operating Expenses
$ 1.35M$ 1.04M$ 1.06M$ 1.17M$ 1.36M
Depreciation and Amortization
$ 0.00$ 2.26M$ 1.03M$ 469.00K$ 1.30M
EBITDA
$ 0.00$ 1.22M$ 0.00$ 0.00$ 0.00
Operating Income
$ -1.33M$ -1.04M$ -1.03M$ -469.00K$ -1.30M
Other Income/Expenses
$ 2.45M$ 2.26M$ 646.00K$ 7.00K$ 1.00K
Pretax Income
$ 1.13M$ 1.22M$ -386.00K$ -462.00K$ -1.30M
Net Income
$ 778.00K$ 98.00K$ -186.00K$ -469.00K$ -1.31M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ 0.01$ 0.00$ 0.00$ -0.01$ -0.03
Diluted EPS
$ 0.01$ 0.00$ 0.00$ -0.01$ -0.03
Weighted Average Shares Outstanding
74.22M 74.24M 74.22M 74.22M 51.10M
Weighted Average Shares Outstanding (Diluted)
74.22M 74.22M 74.22M 74.22M 51.10M
Currency in USD

Enzon Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis